🇺🇸 UTHR — United Therapeutics Corporation

Salud Compra
← Volver

Precio actual

608,49 USD

Máx. histórico

608,49

0 días

Split 2:1 del 23/09/2009

Caída desde máximo

En máximo

Rango 52 semanas

432,53 – 614,23

Variación hoy

+1,19%

Cierre anterior

601,32

Rango de hoy

578,28 – 614,23

Volumen hoy

908.530

Peor caída histórica

-93,18%

12/07/2000 → 10/12/2001

Recuperado en 3311 días

Volatilidad anualizada ⓘ

46,95%

Información
Nombre completo
United Therapeutics Corporation
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
1.400
PER ⓘ
21,57 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
670,93 USD (puede no estar actualizado)
Primera cotización
17/06/1999
Precio actualizado
hace 14 horas
Sobre la empresa

United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.

Splits Registrados en el histórico de precios
Fecha Ratio
23/09/2009 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/06/2021 178,75 181,91 177,75 180,20 +0,96% 2,33% 297.000
18/06/2021 181,56 181,92 177,75 178,49 -2,15% 2,30% 491.700
17/06/2021 182,46 184,55 179,90 182,41 -0,56% 2,55% 215.300
16/06/2021 179,53 184,83 178,18 183,44 +2,80% 3,70% 358.800
15/06/2021 179,22 180,00 176,71 178,45 -0,67% 1,84% 223.000
14/06/2021 179,42 181,90 179,09 179,65 +0,30% 1,57% 335.200
11/06/2021 181,05 181,35 177,07 179,12 -0,76% 2,36% 345.600
10/06/2021 174,97 181,64 174,97 180,49 +3,28% 3,81% 322.300
09/06/2021 170,23 176,43 170,23 174,75 +2,51% 3,64% 381.300
08/06/2021 175,23 175,48 170,06 170,47 -3,08% 3,09% 472.600
07/06/2021 176,91 179,83 174,71 175,89 -0,03% 2,89% 381.100
04/06/2021 175,08 175,97 171,65 175,95 +0,41% 2,47% 401.400
03/06/2021 171,59 176,37 170,12 175,24 +2,09% 3,64% 363.400
02/06/2021 178,03 179,56 170,50 171,66 -3,46% 5,09% 840.300
01/06/2021 186,44 186,70 177,00 177,82 -4,35% 5,20% 404.800
28/05/2021 185,86 187,44 185,01 185,90 +0,09% 1,31% 189.000
27/05/2021 184,77 186,60 182,01 185,74 +0,63% 2,48% 364.800
26/05/2021 185,39 189,84 182,70 184,57 -0,38% 3,85% 613.400
25/05/2021 189,10 189,39 183,77 185,27 -1,77% 2,97% 545.000
24/05/2021 189,98 191,41 187,81 188,61 -0,06% 1,89% 267.700
21/05/2021 191,74 192,50 188,41 188,72 -1,24% 2,13% 277.700
20/05/2021 190,39 192,43 190,00 191,09 +0,67% 1,28% 307.000
19/05/2021 194,59 196,37 189,74 189,82 -2,96% 3,41% 305.000
18/05/2021 197,26 201,08 195,53 195,62 -1,35% 2,81% 333.300
17/05/2021 197,61 199,95 196,65 198,29 +0,21% 1,67% 241.200
14/05/2021 195,39 199,70 194,14 197,87 +2,12% 2,85% 266.300
13/05/2021 196,88 197,87 191,01 193,77 -0,88% 3,48% 382.900
12/05/2021 192,29 198,25 192,00 195,49 +0,61% 3,25% 370.200
11/05/2021 186,24 194,89 185,01 194,30 +2,33% 5,30% 295.400
10/05/2021 193,52 194,86 189,80 189,88 -2,83% 2,61% 304.500